Table 1.

Clinical data for the 15 sporotrichosis cases in the present study.

Patient no.	Clinical form	Disease duration (month)	Location	TNF (pg/ml)	IL-6 (pg/ml)
1	Fixed	2	Face	21.34044297	21.44581527
2	Lymphocutaneous	1	Lower limbs	71.20012408	72.77879742
3	disseminated cutaneous	4	Lower limbs	86.87250613	94.53421187
4	Fixed	12	Upper limbs	27.51110135	24.09024543
5	Fixed	1	Lower limbs	34.27076872	35.81438507
6	Lymphocutaneous	3	Lower limbs	54.74241527	84.46412093
7	disseminated cutaneous	2	Lower limbs	92.12332739	120.332541
8	Lymphocutaneous	5	Lower limbs	49.97764689	145.8153094
9	Disseminated cutaneous	1	Upper limbs	40.27745463	105.6169483
10	Disseminated cutaneous	2	Upper limbs	80.26444335	146.7518219
11	Fixed	5	Face	13.74753296	56.99028894
12	Lymphocutaneous	1	Upper limbs	39.8225295	93.58322097
13	Fixed	2	Upper limbs	43.24949822	75.74668395
14	Fixed	2	Upper limbs	61.11836392	21.56278912
15	Lymphocutaneous	6	Upper limbs	77.17433536	71.32167294